226 related articles for article (PubMed ID: 26542150)
1. Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na(+) and Ca(2+) Channels Permeability.
Sitges M; Chiu LM; Reed RC
Neurochem Res; 2016 Apr; 41(4):758-69. PubMed ID: 26542150
[TBL] [Abstract][Full Text] [Related]
2. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
Sitges M; Chiu LM; Nekrassov V
Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
[TBL] [Abstract][Full Text] [Related]
3. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release.
Sitges M; Guarneros A; Nekrassov V
Neuropharmacology; 2007 Dec; 53(7):854-62. PubMed ID: 17904592
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.
Sitges M; Aldana BI; Reed RC
Neurochem Res; 2016 Jun; 41(6):1365-74. PubMed ID: 26830290
[TBL] [Abstract][Full Text] [Related]
5. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings.
Sitges M; Chiu LM; Guarneros A; Nekrassov V
Neuropharmacology; 2007 Feb; 52(2):598-605. PubMed ID: 17070874
[TBL] [Abstract][Full Text] [Related]
6. Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs.
Sitges M; Sanchez-Tafolla BM; Chiu LM; Aldana BI; Guarneros A
Epilepsy Res; 2011 Oct; 96(3):257-66. PubMed ID: 21737246
[TBL] [Abstract][Full Text] [Related]
7. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes.
Sitges M; Galván E; Nekrassov V
Neurochem Int; 2005 Jun; 46(7):533-40. PubMed ID: 15843047
[TBL] [Abstract][Full Text] [Related]
8. Sertraline inhibits pre-synaptic Na⁺ channel-mediated responses in hippocampus-isolated nerve endings.
Aldana BI; Sitges M
J Neurochem; 2012 Apr; 121(2):197-205. PubMed ID: 22288826
[TBL] [Abstract][Full Text] [Related]
9. The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus.
Gómez CD; Buijs RM; Sitges M
J Neurochem; 2014 Sep; 130(6):770-9. PubMed ID: 24903676
[TBL] [Abstract][Full Text] [Related]
10. Omega-agatoxin-TK is a useful tool to study P-type Ca2+ channel-mediated changes in internal Ca2+ and glutamate release in depolarised brain nerve terminals.
Sitges M; Galindo CA
Neurochem Int; 2005 Jan; 46(1):53-60. PubMed ID: 15567515
[TBL] [Abstract][Full Text] [Related]
11. Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes.
Kammerer M; Rassner MP; Freiman TM; Feuerstein TJ
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):47-57. PubMed ID: 21533993
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels.
Ambrósio AF; Silva AP; Malva JO; Soares-da-Silva P; Carvalho AP; Carvalho CM
Biochem Pharmacol; 2001 May; 61(10):1271-5. PubMed ID: 11322931
[TBL] [Abstract][Full Text] [Related]
13. Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings.
Sitges M; Aldana BI; Chiu LM; Nekrassov V
Neurochem Res; 2009 Mar; 34(3):470-9. PubMed ID: 18712476
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes.
Kammerer M; Brawek B; Freiman TM; Jackisch R; Feuerstein TJ
Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):531-42. PubMed ID: 21448570
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings.
Trejo F; Nekrassov V; Sitges M
Brain Res; 2001 Aug; 909(1-2):59-67. PubMed ID: 11478921
[TBL] [Abstract][Full Text] [Related]
16. Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.
Sitges M; Nekrassov V
Neurochem Res; 1999 Dec; 24(12):1585-91. PubMed ID: 10591410
[TBL] [Abstract][Full Text] [Related]
17. Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels.
Sitges M; Peña F; Chiu LM; Guarneros A
Neurochem Int; 1998 Feb; 32(2):177-90. PubMed ID: 9580510
[TBL] [Abstract][Full Text] [Related]
18. σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.
Lu CW; Lin TY; Wang CC; Wang SJ
J Pharmacol Exp Ther; 2012 May; 341(2):532-42. PubMed ID: 22357973
[TBL] [Abstract][Full Text] [Related]
19. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum.
Waldmeier PC; Martin P; Stöcklin K; Portet C; Schmutz M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):164-72. PubMed ID: 8857593
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
Lin TY; Lu CW; Wang CC; Huang SK; Wang SJ
J Pharmacol Exp Ther; 2014 Oct; 351(1):134-45. PubMed ID: 25047516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
